nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfasalazine—ABCG2—Dactinomycin—sarcoma	0.0887	0.143	CbGbCtD
Sulfasalazine—ABCG2—Mitoxantrone—sarcoma	0.0794	0.128	CbGbCtD
Sulfasalazine—ABCC2—Vincristine—sarcoma	0.0604	0.0976	CbGbCtD
Sulfasalazine—ABCC2—Etoposide—sarcoma	0.0554	0.0894	CbGbCtD
Sulfasalazine—PTGS2—Etoposide—sarcoma	0.0547	0.0883	CbGbCtD
Sulfasalazine—ABCG2—Vincristine—sarcoma	0.0546	0.0882	CbGbCtD
Sulfasalazine—ABCG2—Etoposide—sarcoma	0.0501	0.0808	CbGbCtD
Sulfasalazine—PTGS1—Etoposide—sarcoma	0.0462	0.0746	CbGbCtD
Sulfasalazine—ABCC2—Doxorubicin—sarcoma	0.0378	0.061	CbGbCtD
Sulfasalazine—ABCG2—Doxorubicin—sarcoma	0.0341	0.0551	CbGbCtD
Sulfasalazine—TBXAS1—hip—sarcoma	0.0304	0.144	CbGeAlD
Sulfasalazine—CYP3A5—Vincristine—sarcoma	0.0303	0.0489	CbGbCtD
Sulfasalazine—CYP3A5—Etoposide—sarcoma	0.0277	0.0448	CbGbCtD
Sulfasalazine—TBXAS1—knee—sarcoma	0.0149	0.0707	CbGeAlD
Sulfasalazine—SLC7A11—forelimb zeugopod—sarcoma	0.0118	0.0562	CbGeAlD
Sulfasalazine—TBXAS1—leg—sarcoma	0.00817	0.0388	CbGeAlD
Sulfasalazine—TBXAS1—forelimb—sarcoma	0.00811	0.0385	CbGeAlD
Sulfasalazine—TBXAS1—hindlimb—sarcoma	0.0073	0.0346	CbGeAlD
Sulfasalazine—TBXAS1—appendage—sarcoma	0.00626	0.0297	CbGeAlD
Sulfasalazine—PPARG—dermis—sarcoma	0.00467	0.0222	CbGeAlD
Sulfasalazine—PPARG—periosteum—sarcoma	0.00386	0.0183	CbGeAlD
Sulfasalazine—PPARG—Teniposide—Etoposide—sarcoma	0.00346	1	CbGdCrCtD
Sulfasalazine—PPARG—leg—sarcoma	0.00308	0.0146	CbGeAlD
Sulfasalazine—PPARG—forelimb—sarcoma	0.00306	0.0145	CbGeAlD
Sulfasalazine—TBXAS1—mammary gland—sarcoma	0.00305	0.0145	CbGeAlD
Sulfasalazine—PPARG—hindlimb—sarcoma	0.00275	0.0131	CbGeAlD
Sulfasalazine—PPARG—appendage—sarcoma	0.00236	0.0112	CbGeAlD
Sulfasalazine—ACAT1—hematopoietic system—sarcoma	0.00222	0.0105	CbGeAlD
Sulfasalazine—TBXAS1—myometrium—sarcoma	0.00216	0.0103	CbGeAlD
Sulfasalazine—ACAT1—connective tissue—sarcoma	0.00214	0.0101	CbGeAlD
Sulfasalazine—PTGS2—periosteum—sarcoma	0.00197	0.00937	CbGeAlD
Sulfasalazine—ACAT1—smooth muscle tissue—sarcoma	0.00195	0.00928	CbGeAlD
Sulfasalazine—TBXAS1—hematopoietic system—sarcoma	0.00186	0.00881	CbGeAlD
Sulfasalazine—TBXAS1—connective tissue—sarcoma	0.00179	0.00848	CbGeAlD
Sulfasalazine—SLC46A1—seminal vesicle—sarcoma	0.00174	0.00826	CbGeAlD
Sulfasalazine—ACAT1—cardiac atrium—sarcoma	0.00169	0.008	CbGeAlD
Sulfasalazine—ACAT1—uterus—sarcoma	0.00168	0.00796	CbGeAlD
Sulfasalazine—CHUK—hematopoietic system—sarcoma	0.00165	0.00785	CbGeAlD
Sulfasalazine—SLC46A1—hematopoietic system—sarcoma	0.00165	0.00785	CbGeAlD
Sulfasalazine—TBXAS1—smooth muscle tissue—sarcoma	0.00163	0.00776	CbGeAlD
Sulfasalazine—CHUK—connective tissue—sarcoma	0.00159	0.00756	CbGeAlD
Sulfasalazine—PTGS2—leg—sarcoma	0.00157	0.00747	CbGeAlD
Sulfasalazine—PLA2G1B—hematopoietic system—sarcoma	0.00155	0.00738	CbGeAlD
Sulfasalazine—PLA2G1B—connective tissue—sarcoma	0.0015	0.00711	CbGeAlD
Sulfasalazine—ACAT1—tendon—sarcoma	0.00147	0.00697	CbGeAlD
Sulfasalazine—CHUK—skin of body—sarcoma	0.00144	0.00682	CbGeAlD
Sulfasalazine—PPARG—endothelium—sarcoma	0.00142	0.00676	CbGeAlD
Sulfasalazine—ACAT1—bone marrow—sarcoma	0.00142	0.00675	CbGeAlD
Sulfasalazine—PTGS2—hindlimb—sarcoma	0.00141	0.00667	CbGeAlD
Sulfasalazine—TBXAS1—uterus—sarcoma	0.0014	0.00665	CbGeAlD
Sulfasalazine—PTGS2—cartilage tissue—sarcoma	0.00138	0.00657	CbGeAlD
Sulfasalazine—SLCO1B1—mammary gland—sarcoma	0.00133	0.00632	CbGeAlD
Sulfasalazine—IKBKB—myometrium—sarcoma	0.00131	0.00621	CbGeAlD
Sulfasalazine—TBXAS1—lymphoid tissue—sarcoma	0.00131	0.0062	CbGeAlD
Sulfasalazine—IKBKB—embryo—sarcoma	0.00126	0.00598	CbGeAlD
Sulfasalazine—TBXAS1—tendon—sarcoma	0.00123	0.00583	CbGeAlD
Sulfasalazine—ACAT1—testis—sarcoma	0.00122	0.00577	CbGeAlD
Sulfasalazine—PTGS2—appendage—sarcoma	0.00121	0.00572	CbGeAlD
Sulfasalazine—SLC7A11—smooth muscle tissue—sarcoma	0.0012	0.00569	CbGeAlD
Sulfasalazine—TBXAS1—bone marrow—sarcoma	0.00119	0.00565	CbGeAlD
Sulfasalazine—SLC46A1—lymphoid tissue—sarcoma	0.00116	0.00553	CbGeAlD
Sulfasalazine—CHUK—lymphoid tissue—sarcoma	0.00116	0.00553	CbGeAlD
Sulfasalazine—ACAT1—liver—sarcoma	0.00115	0.00546	CbGeAlD
Sulfasalazine—PPARG—mammary gland—sarcoma	0.00115	0.00545	CbGeAlD
Sulfasalazine—IKBKB—hematopoietic system—sarcoma	0.00112	0.00534	CbGeAlD
Sulfasalazine—SLC46A1—tendon—sarcoma	0.00109	0.0052	CbGeAlD
Sulfasalazine—IKBKB—connective tissue—sarcoma	0.00108	0.00514	CbGeAlD
Sulfasalazine—TBXAS1—testis—sarcoma	0.00102	0.00483	CbGeAlD
Sulfasalazine—IKBKB—smooth muscle tissue—sarcoma	0.00099	0.0047	CbGeAlD
Sulfasalazine—IKBKB—skin of body—sarcoma	0.000977	0.00464	CbGeAlD
Sulfasalazine—TBXAS1—liver—sarcoma	0.000961	0.00456	CbGeAlD
Sulfasalazine—ALOX5—hematopoietic system—sarcoma	0.000932	0.00442	CbGeAlD
Sulfasalazine—CHUK—testis—sarcoma	0.000906	0.0043	CbGeAlD
Sulfasalazine—SLC46A1—testis—sarcoma	0.000906	0.0043	CbGeAlD
Sulfasalazine—ALOX5—connective tissue—sarcoma	0.000897	0.00426	CbGeAlD
Sulfasalazine—ACAT1—lymph node—sarcoma	0.000882	0.00419	CbGeAlD
Sulfasalazine—SLC46A1—liver—sarcoma	0.000857	0.00407	CbGeAlD
Sulfasalazine—CHUK—liver—sarcoma	0.000857	0.00407	CbGeAlD
Sulfasalazine—PLA2G1B—testis—sarcoma	0.000852	0.00404	CbGeAlD
Sulfasalazine—IKBKB—uterus—sarcoma	0.000849	0.00403	CbGeAlD
Sulfasalazine—ALOX5—smooth muscle tissue—sarcoma	0.000821	0.0039	CbGeAlD
Sulfasalazine—SLCO1B1—hematopoietic system—sarcoma	0.000811	0.00385	CbGeAlD
Sulfasalazine—IKBKB—lymphoid tissue—sarcoma	0.000791	0.00376	CbGeAlD
Sulfasalazine—PPARG—embryo—sarcoma	0.000784	0.00372	CbGeAlD
Sulfasalazine—PTGS1—endothelium—sarcoma	0.000761	0.00361	CbGeAlD
Sulfasalazine—SLC7A11—testis—sarcoma	0.000746	0.00354	CbGeAlD
Sulfasalazine—IKBKB—tendon—sarcoma	0.000744	0.00353	CbGeAlD
Sulfasalazine—TBXAS1—lymph node—sarcoma	0.000737	0.0035	CbGeAlD
Sulfasalazine—PTGS2—endothelium—sarcoma	0.000728	0.00345	CbGeAlD
Sulfasalazine—PPARG—hematopoietic system—sarcoma	0.000699	0.00332	CbGeAlD
Sulfasalazine—PPARG—connective tissue—sarcoma	0.000673	0.0032	CbGeAlD
Sulfasalazine—CHUK—lymph node—sarcoma	0.000657	0.00312	CbGeAlD
Sulfasalazine—SLC46A1—lymph node—sarcoma	0.000657	0.00312	CbGeAlD
Sulfasalazine—ALOX5—lymphoid tissue—sarcoma	0.000656	0.00311	CbGeAlD
Sulfasalazine—PPARG—smooth muscle tissue—sarcoma	0.000616	0.00292	CbGeAlD
Sulfasalazine—IKBKB—testis—sarcoma	0.000616	0.00292	CbGeAlD
Sulfasalazine—PPARG—skin of body—sarcoma	0.000608	0.00289	CbGeAlD
Sulfasalazine—ALOX5—bone marrow—sarcoma	0.000597	0.00283	CbGeAlD
Sulfasalazine—IKBKB—liver—sarcoma	0.000582	0.00276	CbGeAlD
Sulfasalazine—PPARG—uterus—sarcoma	0.000528	0.00251	CbGeAlD
Sulfasalazine—ABCG2—myometrium—sarcoma	0.000522	0.00248	CbGeAlD
Sulfasalazine—ALOX5—testis—sarcoma	0.000511	0.00242	CbGeAlD
Sulfasalazine—PPARG—lymphoid tissue—sarcoma	0.000492	0.00234	CbGeAlD
Sulfasalazine—ALOX5—liver—sarcoma	0.000483	0.00229	CbGeAlD
Sulfasalazine—ABCG2—seminal vesicle—sarcoma	0.000472	0.00224	CbGeAlD
Sulfasalazine—PPARG—tendon—sarcoma	0.000463	0.0022	CbGeAlD
Sulfasalazine—PPARG—bone marrow—sarcoma	0.000448	0.00213	CbGeAlD
Sulfasalazine—IKBKB—lymph node—sarcoma	0.000447	0.00212	CbGeAlD
Sulfasalazine—SLCO1B1—liver—sarcoma	0.00042	0.00199	CbGeAlD
Sulfasalazine—PTGS2—myometrium—sarcoma	0.000416	0.00198	CbGeAlD
Sulfasalazine—CYP3A5—hematopoietic system—sarcoma	0.000416	0.00198	CbGeAlD
Sulfasalazine—ABCC2—tendon—sarcoma	0.000407	0.00193	CbGeAlD
Sulfasalazine—PTGS2—embryo—sarcoma	0.0004	0.0019	CbGeAlD
Sulfasalazine—PTGS1—seminal vesicle—sarcoma	0.000393	0.00187	CbGeAlD
Sulfasalazine—PPARG—testis—sarcoma	0.000383	0.00182	CbGeAlD
Sulfasalazine—PTGS2—seminal vesicle—sarcoma	0.000376	0.00179	CbGeAlD
Sulfasalazine—PTGS1—hematopoietic system—sarcoma	0.000374	0.00178	CbGeAlD
Sulfasalazine—ALOX5—lymph node—sarcoma	0.00037	0.00176	CbGeAlD
Sulfasalazine—PPARG—liver—sarcoma	0.000362	0.00172	CbGeAlD
Sulfasalazine—PTGS1—connective tissue—sarcoma	0.00036	0.00171	CbGeAlD
Sulfasalazine—PTGS2—hematopoietic system—sarcoma	0.000357	0.0017	CbGeAlD
Sulfasalazine—PTGS2—connective tissue—sarcoma	0.000344	0.00163	CbGeAlD
Sulfasalazine—ABCG2—uterus—sarcoma	0.000339	0.00161	CbGeAlD
Sulfasalazine—ABCC2—testis—sarcoma	0.000337	0.0016	CbGeAlD
Sulfasalazine—PTGS1—smooth muscle tissue—sarcoma	0.000329	0.00156	CbGeAlD
Sulfasalazine—PTGS1—skin of body—sarcoma	0.000325	0.00154	CbGeAlD
Sulfasalazine—ABCC2—liver—sarcoma	0.000319	0.00151	CbGeAlD
Sulfasalazine—PTGS2—smooth muscle tissue—sarcoma	0.000315	0.00149	CbGeAlD
Sulfasalazine—PTGS2—skin of body—sarcoma	0.000311	0.00148	CbGeAlD
Sulfasalazine—ABCG2—bone marrow—sarcoma	0.000287	0.00136	CbGeAlD
Sulfasalazine—PTGS1—cardiac atrium—sarcoma	0.000284	0.00135	CbGeAlD
Sulfasalazine—PTGS1—uterus—sarcoma	0.000282	0.00134	CbGeAlD
Sulfasalazine—PPARG—lymph node—sarcoma	0.000278	0.00132	CbGeAlD
Sulfasalazine—PTGS2—uterus—sarcoma	0.00027	0.00128	CbGeAlD
Sulfasalazine—PTGS2—lymphoid tissue—sarcoma	0.000252	0.00119	CbGeAlD
Sulfasalazine—PTGS1—tendon—sarcoma	0.000247	0.00117	CbGeAlD
Sulfasalazine—ABCG2—testis—sarcoma	0.000246	0.00117	CbGeAlD
Sulfasalazine—ABCC2—lymph node—sarcoma	0.000244	0.00116	CbGeAlD
Sulfasalazine—PTGS2—tendon—sarcoma	0.000237	0.00112	CbGeAlD
Sulfasalazine—ABCG2—liver—sarcoma	0.000232	0.0011	CbGeAlD
Sulfasalazine—PTGS2—bone marrow—sarcoma	0.000229	0.00109	CbGeAlD
Sulfasalazine—CYP3A5—liver—sarcoma	0.000216	0.00102	CbGeAlD
Sulfasalazine—PTGS1—testis—sarcoma	0.000205	0.000973	CbGeAlD
Sulfasalazine—PTGS2—liver—sarcoma	0.000185	0.000879	CbGeAlD
Sulfasalazine—ABCG2—lymph node—sarcoma	0.000178	0.000845	CbGeAlD
Sulfasalazine—PTGS1—lymph node—sarcoma	0.000149	0.000705	CbGeAlD
Sulfasalazine—PTGS2—lymph node—sarcoma	0.000142	0.000674	CbGeAlD
Sulfasalazine—IKBKB—Innate Immune System—PDGFRB—sarcoma	5.82e-05	0.000349	CbGpPWpGaD
Sulfasalazine—IKBKB—Fc epsilon receptor (FCERI) signaling—KRAS—sarcoma	5.81e-05	0.000349	CbGpPWpGaD
Sulfasalazine—CHUK—DAP12 signaling—HRAS—sarcoma	5.79e-05	0.000348	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—ENO2—sarcoma	5.74e-05	0.000345	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—PDGFRA—sarcoma	5.73e-05	0.000344	CbGpPWpGaD
Sulfasalazine—CHUK—Downstream signaling events of B Cell Receptor (BCR)—HRAS—sarcoma	5.71e-05	0.000343	CbGpPWpGaD
Sulfasalazine—IKBKB—B Cell Activation—EGFR—sarcoma	5.69e-05	0.000342	CbGpPWpGaD
Sulfasalazine—PTGS2—Spinal Cord Injury—MYC—sarcoma	5.68e-05	0.000341	CbGpPWpGaD
Sulfasalazine—CHUK—NGF signalling via TRKA from the plasma membrane—KRAS—sarcoma	5.68e-05	0.000341	CbGpPWpGaD
Sulfasalazine—PPARG—Developmental Biology—CREB1—sarcoma	5.62e-05	0.000338	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—FOXO1—sarcoma	5.6e-05	0.000336	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—PDGFRB—sarcoma	5.59e-05	0.000336	CbGpPWpGaD
Sulfasalazine—IKBKB—Cytokine Signaling in Immune system—IL2—sarcoma	5.57e-05	0.000335	CbGpPWpGaD
Sulfasalazine—PTGS2—Spinal Cord Injury—EGFR—sarcoma	5.56e-05	0.000334	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—MDM2—sarcoma	5.53e-05	0.000332	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—PDGFRA—sarcoma	5.5e-05	0.00033	CbGpPWpGaD
Sulfasalazine—PPARG—Circadian rythm related genes—TP53—sarcoma	5.48e-05	0.000329	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by FGFR in disease—HRAS—sarcoma	5.45e-05	0.000327	CbGpPWpGaD
Sulfasalazine—CHUK—Fc epsilon receptor (FCERI) signaling—HRAS—sarcoma	5.45e-05	0.000327	CbGpPWpGaD
Sulfasalazine—CHUK—DAP12 interactions—HRAS—sarcoma	5.45e-05	0.000327	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by EGFR—HRAS—sarcoma	5.4e-05	0.000324	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—PTPRC—sarcoma	5.39e-05	0.000324	CbGpPWpGaD
Sulfasalazine—IKBKB—MAPK Signaling Pathway—TP53—sarcoma	5.39e-05	0.000323	CbGpPWpGaD
Sulfasalazine—IKBKB—B Cell Activation—KRAS—sarcoma	5.38e-05	0.000323	CbGpPWpGaD
Sulfasalazine—CHUK—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	5.36e-05	0.000322	CbGpPWpGaD
Sulfasalazine—IKBKB—Insulin Signaling—HRAS—sarcoma	5.36e-05	0.000322	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by EGFR in Cancer—HRAS—sarcoma	5.35e-05	0.000321	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by PDGF—HRAS—sarcoma	5.33e-05	0.00032	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—PLCG1—sarcoma	5.28e-05	0.000317	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by NGF—SRC—sarcoma	5.27e-05	0.000317	CbGpPWpGaD
Sulfasalazine—SLC7A11—Hemostasis—TP53—sarcoma	5.27e-05	0.000317	CbGpPWpGaD
Sulfasalazine—PPARG—Developmental Biology—MMP2—sarcoma	5.24e-05	0.000314	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—CTNNB1—sarcoma	5.21e-05	0.000313	CbGpPWpGaD
Sulfasalazine—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—HRAS—sarcoma	5.18e-05	0.000311	CbGpPWpGaD
Sulfasalazine—CHUK—Cytokine Signaling in Immune system—NRAS—sarcoma	5.16e-05	0.00031	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—TLE1—sarcoma	5.15e-05	0.000309	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—ENO2—sarcoma	5.12e-05	0.000308	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—HBA1—sarcoma	5.09e-05	0.000306	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by NGF—NRAS—sarcoma	5.07e-05	0.000305	CbGpPWpGaD
Sulfasalazine—CHUK—B Cell Activation—HRAS—sarcoma	5.04e-05	0.000303	CbGpPWpGaD
Sulfasalazine—SLC7A11—Hemostasis—HRAS—sarcoma	5.04e-05	0.000303	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—ATF1—sarcoma	5.01e-05	0.000301	CbGpPWpGaD
Sulfasalazine—IKBKB—Fc epsilon receptor (FCERI) signaling—HRAS—sarcoma	4.94e-05	0.000297	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—KIT—sarcoma	4.9e-05	0.000294	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—PTPRC—sarcoma	4.89e-05	0.000294	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—PLCG1—sarcoma	4.87e-05	0.000293	CbGpPWpGaD
Sulfasalazine—CHUK—NGF signalling via TRKA from the plasma membrane—HRAS—sarcoma	4.83e-05	0.00029	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—sarcoma	4.82e-05	0.000289	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—sarcoma	4.81e-05	0.000289	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—PLCG1—sarcoma	4.79e-05	0.000287	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling by NGF—SRC—sarcoma	4.78e-05	0.000287	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—sarcoma	4.77e-05	0.000287	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—SRC—sarcoma	4.7e-05	0.000283	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—KIT—sarcoma	4.7e-05	0.000282	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—CXCR4—sarcoma	4.68e-05	0.000281	CbGpPWpGaD
Sulfasalazine—IKBKB—Cytokine Signaling in Immune system—NRAS—sarcoma	4.68e-05	0.000281	CbGpPWpGaD
Sulfasalazine—PTGS2—Spinal Cord Injury—TP53—sarcoma	4.67e-05	0.00028	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—TLE1—sarcoma	4.67e-05	0.00028	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—CREB1—sarcoma	4.66e-05	0.00028	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by NGF—EGFR—sarcoma	4.62e-05	0.000278	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling by NGF—NRAS—sarcoma	4.6e-05	0.000276	CbGpPWpGaD
Sulfasalazine—IKBKB—B Cell Activation—HRAS—sarcoma	4.57e-05	0.000275	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—ATF1—sarcoma	4.55e-05	0.000273	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—NRAS—sarcoma	4.53e-05	0.000272	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—CREB1—sarcoma	4.48e-05	0.000269	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—KIT—sarcoma	4.44e-05	0.000267	CbGpPWpGaD
Sulfasalazine—CHUK—Cytokine Signaling in Immune system—KRAS—sarcoma	4.44e-05	0.000267	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by NGF—KRAS—sarcoma	4.37e-05	0.000262	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—TLE1—sarcoma	4.35e-05	0.000261	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—PLCG1—sarcoma	4.35e-05	0.000261	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—VEGFC—sarcoma	4.34e-05	0.000261	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—sarcoma	4.31e-05	0.000259	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—KIT—sarcoma	4.27e-05	0.000256	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—CREB1—sarcoma	4.23e-05	0.000254	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—MYC—sarcoma	4.22e-05	0.000253	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—sarcoma	4.2e-05	0.000252	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling by NGF—EGFR—sarcoma	4.19e-05	0.000252	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—EGFR—sarcoma	4.12e-05	0.000248	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—CREB1—sarcoma	4.06e-05	0.000244	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—ENO2—sarcoma	4.03e-05	0.000242	CbGpPWpGaD
Sulfasalazine—IKBKB—Cytokine Signaling in Immune system—KRAS—sarcoma	4.03e-05	0.000242	CbGpPWpGaD
Sulfasalazine—PPARG—Developmental Biology—CTNNB1—sarcoma	4.01e-05	0.000241	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—HBA1—sarcoma	4.01e-05	0.000241	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling by NGF—KRAS—sarcoma	3.96e-05	0.000238	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—VEGFC—sarcoma	3.94e-05	0.000236	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—NPM1—sarcoma	3.93e-05	0.000236	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—KRAS—sarcoma	3.9e-05	0.000234	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	3.87e-05	0.000232	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—MDM2—sarcoma	3.86e-05	0.000232	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	3.78e-05	0.000227	CbGpPWpGaD
Sulfasalazine—CHUK—Cytokine Signaling in Immune system—HRAS—sarcoma	3.78e-05	0.000227	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—FOXO1—sarcoma	3.74e-05	0.000225	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—PDGFRB—sarcoma	3.74e-05	0.000224	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—ENO2—sarcoma	3.73e-05	0.000224	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by NGF—HRAS—sarcoma	3.71e-05	0.000223	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—HBA1—sarcoma	3.71e-05	0.000223	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—MDM2—sarcoma	3.7e-05	0.000222	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—PDGFRA—sarcoma	3.68e-05	0.000221	CbGpPWpGaD
Sulfasalazine—PPARG—Developmental Biology—SRC—sarcoma	3.63e-05	0.000218	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—ENO2—sarcoma	3.59e-05	0.000215	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	3.57e-05	0.000215	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—HBA1—sarcoma	3.57e-05	0.000214	CbGpPWpGaD
Sulfasalazine—PPARG—Developmental Biology—VEGFA—sarcoma	3.53e-05	0.000212	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—MDM2—sarcoma	3.5e-05	0.00021	CbGpPWpGaD
Sulfasalazine—PPARG—Developmental Biology—NRAS—sarcoma	3.49e-05	0.00021	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—FLT1—sarcoma	3.47e-05	0.000208	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—FOXO1—sarcoma	3.46e-05	0.000208	CbGpPWpGaD
Sulfasalazine—PPARG—Generic Transcription Pathway—MYC—sarcoma	3.45e-05	0.000207	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—PDGFRB—sarcoma	3.45e-05	0.000207	CbGpPWpGaD
Sulfasalazine—IKBKB—Cytokine Signaling in Immune system—HRAS—sarcoma	3.42e-05	0.000206	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—PLCG1—sarcoma	3.42e-05	0.000206	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—PLCG1—sarcoma	3.41e-05	0.000205	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—ENO2—sarcoma	3.4e-05	0.000204	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—PDGFRA—sarcoma	3.4e-05	0.000204	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—FOXO1—sarcoma	3.4e-05	0.000204	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—PDGFRB—sarcoma	3.39e-05	0.000204	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling by NGF—HRAS—sarcoma	3.37e-05	0.000202	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—MDM2—sarcoma	3.36e-05	0.000202	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—JUN—sarcoma	3.35e-05	0.000201	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—PDGFRA—sarcoma	3.34e-05	0.0002	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—CTNNB1—sarcoma	3.33e-05	0.0002	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—HRAS—sarcoma	3.31e-05	0.000199	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CXCR4—sarcoma	3.28e-05	0.000197	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—ATF1—sarcoma	3.24e-05	0.000195	CbGpPWpGaD
Sulfasalazine—PPARG—Developmental Biology—EGFR—sarcoma	3.18e-05	0.000191	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	3.18e-05	0.000191	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—PLCG1—sarcoma	3.17e-05	0.00019	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—FLT1—sarcoma	3.15e-05	0.000189	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—PLCG1—sarcoma	3.09e-05	0.000186	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—PLCG1—sarcoma	3.04e-05	0.000183	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—JUN—sarcoma	3.04e-05	0.000183	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—CTNNB1—sarcoma	3.02e-05	0.000181	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—SRC—sarcoma	3.01e-05	0.000181	CbGpPWpGaD
Sulfasalazine—PPARG—Developmental Biology—KRAS—sarcoma	3e-05	0.00018	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CXCR4—sarcoma	2.97e-05	0.000178	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—ATF1—sarcoma	2.94e-05	0.000176	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—NRAS—sarcoma	2.89e-05	0.000174	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—SRC—sarcoma	2.89e-05	0.000173	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—PLCG1—sarcoma	2.89e-05	0.000173	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—KIT—sarcoma	2.85e-05	0.000171	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—ENO2—sarcoma	2.85e-05	0.000171	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—HBA1—sarcoma	2.83e-05	0.00017	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—NRAS—sarcoma	2.78e-05	0.000167	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—CXCR4—sarcoma	2.77e-05	0.000167	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—SRC—sarcoma	2.73e-05	0.000164	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—CREB1—sarcoma	2.72e-05	0.000163	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—ENO2—sarcoma	2.68e-05	0.000161	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—HBA1—sarcoma	2.66e-05	0.00016	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—EGFR—sarcoma	2.64e-05	0.000158	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—KIT—sarcoma	2.63e-05	0.000158	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—NRAS—sarcoma	2.62e-05	0.000158	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—SRC—sarcoma	2.62e-05	0.000157	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—KIT—sarcoma	2.59e-05	0.000155	CbGpPWpGaD
Sulfasalazine—PPARG—Developmental Biology—HRAS—sarcoma	2.55e-05	0.000153	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—IGF1R—sarcoma	2.54e-05	0.000153	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—EGFR—sarcoma	2.53e-05	0.000152	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—NRAS—sarcoma	2.52e-05	0.000151	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—CREB1—sarcoma	2.51e-05	0.000151	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—KRAS—sarcoma	2.49e-05	0.00015	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—CREB1—sarcoma	2.46e-05	0.000148	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—FOXO1—sarcoma	2.42e-05	0.000145	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—PLCG1—sarcoma	2.42e-05	0.000145	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—PDGFRB—sarcoma	2.42e-05	0.000145	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—KRAS—sarcoma	2.39e-05	0.000144	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—EGFR—sarcoma	2.39e-05	0.000144	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—PDGFRA—sarcoma	2.38e-05	0.000143	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—IGF1R—sarcoma	2.31e-05	0.000138	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—EGFR—sarcoma	2.3e-05	0.000138	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—PLCG1—sarcoma	2.27e-05	0.000136	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—KRAS—sarcoma	2.26e-05	0.000136	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—MDM2—sarcoma	2.25e-05	0.000135	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—FOXO1—sarcoma	2.2e-05	0.000132	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—PDGFRB—sarcoma	2.19e-05	0.000132	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—KRAS—sarcoma	2.17e-05	0.00013	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—PDGFRA—sarcoma	2.16e-05	0.00013	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—HRAS—sarcoma	2.12e-05	0.000127	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—MDM2—sarcoma	2.07e-05	0.000125	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—FOXO1—sarcoma	2.05e-05	0.000123	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—PDGFRB—sarcoma	2.04e-05	0.000123	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—MDM2—sarcoma	2.04e-05	0.000122	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—HRAS—sarcoma	2.03e-05	0.000122	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—PDGFRA—sarcoma	2.01e-05	0.000121	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—IL2—sarcoma	2.01e-05	0.000121	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—KDR—sarcoma	2e-05	0.00012	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—JUN—sarcoma	1.95e-05	0.000117	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—CTNNB1—sarcoma	1.94e-05	0.000116	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—HRAS—sarcoma	1.92e-05	0.000115	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—KIT—sarcoma	1.84e-05	0.000111	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—HRAS—sarcoma	1.84e-05	0.000111	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—IL2—sarcoma	1.82e-05	0.000109	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—KDR—sarcoma	1.82e-05	0.000109	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—CTNNB1—sarcoma	1.79e-05	0.000107	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—JUN—sarcoma	1.77e-05	0.000106	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—CTNNB1—sarcoma	1.76e-05	0.000106	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CREB1—sarcoma	1.76e-05	0.000105	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—SRC—sarcoma	1.75e-05	0.000105	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—NRAS—sarcoma	1.69e-05	0.000101	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—KIT—sarcoma	1.67e-05	0.0001	CbGpPWpGaD
Sulfasalazine—PPARG—Gene Expression—MYC—sarcoma	1.66e-05	9.99e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—SRC—sarcoma	1.62e-05	9.71e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CREB1—sarcoma	1.59e-05	9.56e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—SRC—sarcoma	1.59e-05	9.54e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—KIT—sarcoma	1.56e-05	9.37e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—NRAS—sarcoma	1.56e-05	9.34e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—EGFR—sarcoma	1.54e-05	9.22e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—NRAS—sarcoma	1.53e-05	9.18e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—CREB1—sarcoma	1.49e-05	8.92e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—MDM2—sarcoma	1.45e-05	8.72e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—KRAS—sarcoma	1.45e-05	8.71e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—MYC—sarcoma	1.45e-05	8.7e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—EGFR—sarcoma	1.42e-05	8.51e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—EGFR—sarcoma	1.39e-05	8.36e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—KRAS—sarcoma	1.34e-05	8.04e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—MDM2—sarcoma	1.32e-05	7.91e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—KRAS—sarcoma	1.32e-05	7.9e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—IL2—sarcoma	1.3e-05	7.8e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CCND1—sarcoma	1.27e-05	7.6e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—JUN—sarcoma	1.26e-05	7.58e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CTNNB1—sarcoma	1.25e-05	7.53e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—HRAS—sarcoma	1.23e-05	7.4e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—MDM2—sarcoma	1.23e-05	7.38e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—IL2—sarcoma	1.18e-05	7.07e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CCND1—sarcoma	1.15e-05	6.89e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—JUN—sarcoma	1.15e-05	6.88e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—HRAS—sarcoma	1.14e-05	6.84e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CTNNB1—sarcoma	1.14e-05	6.82e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—SRC—sarcoma	1.13e-05	6.8e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—HRAS—sarcoma	1.12e-05	6.71e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—VEGFA—sarcoma	1.1e-05	6.62e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—NRAS—sarcoma	1.09e-05	6.54e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—CTNNB1—sarcoma	1.06e-05	6.37e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—SRC—sarcoma	1.03e-05	6.17e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—MYC—sarcoma	1.02e-05	6.1e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—VEGFA—sarcoma	1e-05	6.01e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—EGFR—sarcoma	9.93e-06	5.96e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—NRAS—sarcoma	9.88e-06	5.93e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—SRC—sarcoma	9.58e-06	5.75e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—KRAS—sarcoma	9.38e-06	5.63e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—NRAS—sarcoma	9.22e-06	5.54e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—MYC—sarcoma	9.2e-06	5.53e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—EGFR—sarcoma	9e-06	5.41e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—MYC—sarcoma	8.59e-06	5.16e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—KRAS—sarcoma	8.5e-06	5.11e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—EGFR—sarcoma	8.4e-06	5.04e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—TP53—sarcoma	8.34e-06	5.01e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—HRAS—sarcoma	7.97e-06	4.79e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—KRAS—sarcoma	7.93e-06	4.76e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—TP53—sarcoma	7.56e-06	4.54e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—HRAS—sarcoma	7.23e-06	4.34e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—HRAS—sarcoma	6.74e-06	4.05e-05	CbGpPWpGaD
